Current pharmacotherapy for endometriosis

Simone Ferrero; Valentino Remorgida; Pier Luigi Venturini; Venturini PL

doi:10.1517/14656561003685880

Current pharmacotherapy for endometriosis

Simone Ferrero, Valentino Remorgida, Pier Luigi Venturini, Venturini PL

Expert opinion on pharmacotherapy · 2010 · vol. 11(7) , pp. 1123–1134 · doi:10.1517/14656561003685880 · PMID:20230308 · W2137876945

Review OA: closed CC0 ⤵ 48 in-corpus citations

View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This review examined observational and randomized studies on medical therapies for endometriosis, finding they effectively reduce pain symptoms but often lead to recurrence upon discontinuation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

IMPORTANCE OF THE FIELD: Medical therapy is the most commonly used treatment for endometriosis. In particular, the administration of hormonal therapies aims to improve symptoms with minimal adverse effects. AREAS COVERED IN THIS REVIEW: Observational and randomized studies evaluating the efficacy of medical therapy on symptoms associated with endometriosis were reviewed. We searched Medline, Embase and the Cochrane Library up to December 2009. WHAT THE READER WILL GAIN: The reader will obtain information on the available medical therapies used to treat endometriosis-related symptoms either after surgery or as an alternative to the surgical excision of endometriosis. The effectiveness of therapies, the dose of drugs, the length of treatment and the adverse effects are examined. TAKE HOME MESSAGE: Medical therapies can efficaciously reduce the severity of pain symptoms caused by endometriosis. Recurrence of symptoms is common after discontinuation of medical therapies; therefore, the choice of the therapy should be based not only on the improvements of symptoms but also on the potential adverse effects and patients' satisfaction.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Anti-Inflammatory Agents, Non-Steroidal Endometriosis Hormones Animals Animals Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal Combined Modality Therapy Combined Modality Therapy Dose-Response Relationship, Drug Dose-Response Relationship, Drug Endometriosis Endometriosis Endometriosis Endometriosis Female Female Hormones Hormones Hormones

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (100)

Cited by (49)

Source provenance

europepmc: last seen: 2026-10-15T06:08:49.021275+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-10-08T21:07:26.396758+00:00

License: CC0 · commercial use OK

[1] A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex

[2] Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex

[3] Antiangiogenic therapies in endometriosis via openalex

[4] A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis via openalex

[5] Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target via openalex

[6] Changes in quality of life after hormonal treatment of endometriosis via openalex

[7] Changes in quality of life after hormonal treatment of endometriosis via openalex

[8] Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex

[9] Conservative laparoscopic excision of endometriosis by sharp dissection: life table analysis of reoperation and persistent or recurrent disease via openalex

[10] Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex

[11] Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis via openalex

[12] Danazol for pelvic pain associated with endometriosis via openalex

[13] Deep dyspareunia and sex life after laparoscopic excision of endometriosis via openalex

[14] Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis via openalex

[15] Diagnosis and management of bladder endometriosis via openalex

[16] Diagnosis and Management of Bladder Endometriosis via openalex

[17] Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex

[18] Effect of norethindrone acetate in the treatment of symptomatic endometriosis via openalex

[19] Effects of triptorelin versus placebo on the symptoms of endometriosis via openalex

[20] Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study via openalex

[21] Endometriosis via openalex

[22] Endometriosis and the estrogen threshold theory. Relation to surgical and medical treatment via openalex

[23] Endometriosis in pregnant and non-pregnant women at tubal sterilization via openalex

[24] Endometriosis: Prevalence and anatomical distribution of endometriosis in women with selected gynaecological conditions: results from a multicentric Italian study via openalex

[25] Endometriosis therapy with medroxyprogesterone acetate via openalex

[26] Endometriosis treated with lynestrenol via openalex

[27] Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial. Gruppo Italiano per lo Studio dell'Endometriosi via openalex

[28] Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis via openalex

[29] Future perspectives in the medical treatment of endometriosis via openalex

[30] Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. Gestrinone Italian Study Group via openalex

[31] GnRH analogue remarkably down-regulates inflammatory proteins in peritoneal fluid proteome of women with endometriosis via openalex

[32] Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex

[33] Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial via openalex

[34] Histological impact of medical therapy--clinical implications via openalex

[35] Impact of gestrinone on the course of asymptomatic endometriosis via openalex

[36] Indomethacin and fertility in experimental endometriosis via openalex

[37] Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model via openalex

[38] Laparoscopic surgery for pelvic pain associated with endometriosis via openalex

[39] Laparoscopy in 100 women with chronic pelvic pain via openalex

[40] Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis via openalex

[41] Letrozole and norethisterone acetate in rectovaginal endometriosis via openalex

[42] Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group via openalex

[43] Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial via openalex

[44] Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis via openalex

[45] Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex

[46] Management of endometriosis with oral medroxyprogesterone acetate via openalex

[47] Megestrol acetate for treatment of endometriosis via openalex

[48] Modern combined oral contraceptives for pain associated with endometriosis via openalex

[49] Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex

[50] Nafarelin for endometriosis: A large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex

[51] Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis via openalex

[52] Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study via openalex

[53] Ovulation suppression for endometriosis via openalex

[54] Pain, quality of life and complications following the radical resection of rectovaginal endometriosis via openalex

[55] Pharmacological treatment of endometriosis: experience with aromatase inhibitors via openalex

[56] Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis via openalex

[57] Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery via openalex

[58] Postoperative oral contraceptive exposure and risk of endometrioma recurrence via openalex

[59] Prevalence and anatomical distribution of endometriosis in women with selected gynaecological conditions results from a multicentric Italian study via openalex

[60] Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis via openalex

[61] Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial via openalex

[62] Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib via openalex

[63] Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study via openalex

[64] Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain via openalex

[65] Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex

[66] Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor via openalex

[67] Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice via openalex

[68] Surgical treatment of deep endometriosis and risk of recurrence via openalex

[69] Surgical treatment of deep endometriosis and risk of recurrence via openalex

[70] The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2-5 year follow-up via openalex

[71] The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial via openalex

[72] The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up via openalex

[73] The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease via openalex

[74] The role of progestins in treating the pain of endometriosis via openalex

[75] The treatment of endometriosis by oral progestogens via openalex

[76] The treatment of endometriosis with Danazol via openalex

[77] Treatment of endometriosis via openalex

[78] Treatment of severe postmenopausal endometriosis with an aromatase inhibitor via openalex

[79] Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate via openalex

[80] Triptorelin improves intestinal symptoms among patients with colorectal endometriosis via openalex

[81] Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex

[82] Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis via openalex

[83] Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis via openalex

[84] Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group via openalex

[85] W2409164901 via openalex

[86] W2046683546 via openalex

[87] W2412063026 via openalex

[88] W2415755045 via openalex

[89] W1983655425 via openalex

[90] W1978085719 via openalex

[91] W4211081176 via openalex

[92] W2123134517 via openalex

[93] W2157853773 via openalex

[94] W2228635764 via openalex

[95] W2036037981 via openalex

[96] W2159803441 via openalex

[97] W2287931800 via openalex

[98] W2343033730 via openalex

[99] W2344629823 via openalex

[100] W2130203785 via openalex